Doctor Details

Journals & Publications

1. Hue, S. S.-S. et al. (2023). Tissue-Specific microRNA Expression Profiling to Derive Novel Biomarkers for the Diagnosis and Subtyping of Small B-Cell Lymphomas. Cancers. (2023 IF: 6.6)
2. Hoppe, M. M., Hue, S.S.S et al. (2023). Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma. Cancer Discov. (2023 IF 28.2)
3. Wah, N. W., Hue, S.S.S et al. (2023). Clinicopathologic and Molecular Characteristics of Epstein-Barr Virus–Associated Smooth Muscle Tumor Compared With Those of Leiomyoma and Leiomyosarcoma. Mod. Pathol. (2023 IF 8.2)
4. Hue, S.-S. S., Ng, S.-B., Wang, S., Tan, S.-Y. (2022). Cellular Origins and Pathogenesis of Gastrointestinal NK- and T-Cell Lymphoproliferative Disorders. Cancers. (2023 IF: 6.6)
5. Dashraath, P., Hue, S.S.S et al. (2022). Interferon shrinks spleen in pregnant patient with myeloproliferative neoplasm. The Lancet. (2023 IF: 202.731)
6. Tan, H. M., … Hue, S.S.S. (2022). MicroRNAs as Potential Biomarkers in the Differential Diagnosis of Lipomatous Tumors and Their Mimics. Int. J. Mol. Sci. (2023 IF 6.2)
7. Hue, S. S.-S., Oon, M. L., Wang, S., Tan, S.-Y., Ng, S.-B. (2021). Epstein–Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach. Pathology (Phila.). (2023 IF: 4.5)
8. Hue, S. et al. (2020). Terminal deoxynucleotidyl transferase negative B-lymphoblastic leukaemia/lymphoma with CD138 expression. Pathology (Phila.). (2023 IF: 4.5)
9. Mzoughi, S., Hue, S.S.S et al. (2020). PRDM15 is a key regulator of metabolism critical to sustain B-cell lymphomagenesis. Nat. Commun. (2023 IF: 17.69)
10. de Mel, S., Hue, S.S.S et al. (2019). Molecular pathogenic pathways in extranodal NK/T cell lymphoma. J. Hematol. Oncol. (2023 IF 23.17)